Compare Amphastar Pharmaceuticals Inc (AMPH) vs TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock (TTWO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock — how do they compare? Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $863.95M), while TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock trades at $250.25 (market cap $47.41B). The key difference: TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock is far larger — about 54.9× Amphastar Pharmaceuticals Inc's market cap, and TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock is trading nearer its 52-week high, Amphastar Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| AMPH | TTWO | |
|---|---|---|
Market Cap | $863.95M | $47.41B |
Sector | Health | Media |
52-Week High | $30.81 | $262.29 |
52-Week Low | $16.87 | $189.69 |
Enterprise Value | $1.26B | $48.53B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMPH trades at $20.78, up 4.9% today, with a bullish technical signal supported by moving averages. The stock shows mixed earnings performance with Q2 2026 beating estimates but Q1 and Q4 2025 missing. Fundamentals remain solid with a 10.76% net margin and reasonable valuation at 12.02 P/E. Recent news highlights Q2 2026 results and strategic shift toward proprietary drugs.
Outlook is cautiously optimistic with growth supported by new product launches, though regulatory risks and earnings volatility pose challenges. Analyst sentiment is mixed with 25% buy ratings but majority hold recommendations. The stock offers value but requires monitoring of FDA developments and earnings consistency.
Take-Two Interactive (TTWO) trades at $246.50, up 6.04% on the day, with a bullish technical signal and strong analyst support. Recent Q1 2027 earnings beat expectations, driven by NBA 2K and Grand Theft Auto performance, while net income remains negative. The stock shows bullish moving averages and neutral oscillators, with support near $236 and resistance at $252.
Outlook hinges on GTA VI's November launch, with unprecedented preorders fueling optimism, but risks include sustained losses and high debt. Analysts project 22% upside to a $299.60 consensus target, with 79% recommending Buy. Investors face volatility from execution risks amid bullish sentiment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock
Found in 1993, Take-Two consists of three wholly owned labels, Rockstar Games, 2K, and Zynga. The firm is one of the world's largest independent video game publishers on consoles, PCs, smartphones, and tablets. Take-Two's franchise portfolio is headlined by Grand Theft Auto (345 million units sold) and contains other well-known titles such as NBA 2K, Civilization, Borderlands, Bioshock, and Xcom. Zynga mobile titles include Farmville, Empires & Puzzles, and CSR Racing.
Read more on TTWO →
